Amryt Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 1,470,740 | 2.3% |
| VC/PE Firms | 8,857,269 | 13.8% |
| General Public | 13,600,286 | 21.3% |
| Hedge Funds | 16,266,791 | 25.4% |
| Institutions | 23,795,879 | 37.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 8,857,269 | US$130.2m | 0% | 65.89% | |||
| 6,333,552 | US$93.1m | 0% | 2.71% | |||
| 6,333,239 | US$93.1m | 1.69% | 36.77% | |||
| 3,600,000 | US$52.9m | 0% | 2.19% | |||
| 2,668,843 | US$39.2m | 0% | 17.54% | |||
| 2,277,964 | US$33.5m | 0% | 0.19% | |||
| 2,098,993 | US$30.9m | 5% | 14.98% | |||
| 2,000,000 | US$29.4m | 0% | 1.34% | |||
| 1,699,975 | US$25.0m | 2.98% | 0.05% | |||
| 1,437,458 | US$21.1m | 0% | 1.95% | |||
| 1,362,700 | US$20.0m | 0% | 1.09% | |||
| 1,325,625 | US$19.5m | 0% | 0.47% | |||
| 1,309,234 | US$19.2m | 0% | 0.46% | |||
| 1,300,062 | US$19.1m | 0% | 0.29% | |||
| 978,000 | US$14.4m | -23.1% | 0.36% | |||
| 704,616 | US$10.4m | 0.46% | no data | |||
| 631,942 | US$9.3m | 0% | 1.48% | |||
| 505,000 | US$7.4m | 0% | 1.92% | |||
| 466,712 | US$6.9m | 0% | 0.76% | |||
| 449,737 | US$6.6m | 0% | 5.59% | |||
| 392,720 | US$5.8m | 2.61% | no data | |||
| 328,904 | US$4.8m | 2.1% | no data | |||
| 315,182 | US$4.6m | 0% | 1.29% | |||
| 304,715 | US$4.5m | 0% | 0.97% | |||
| 293,398 | US$4.3m | 27.5% | no data |